Exited position

Daniel Loeb’s Thermo Fisher Scientific Inc (TMO) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Third Point LLCVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2013Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares2.50MHighest verified quarter-end share count
Quarters reported5Verified quarters with shares above zero
What happened?

Third Point LLC first reported Thermo Fisher Scientific Inc in Q1 2013. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Third Point LLC sold the entire position in Q1 2026, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2026
Sold the entire position−50.00K shares · No shares reported at quarter-end
Q4 2025
New position+50.00K shares · 50.00K shares reported
Filing context

Quarter-end price $579.45 · Estimated holding basis $579.45

Q1 2025
Sold the entire position−350.00K shares · No shares reported at quarter-end
Q4 2024
New position+350.00K shares · 350.00K shares reported
Filing context

Quarter-end price $520.23 · Estimated holding basis $520.23

Q4 2013
Sold the entire position−1.55M shares · No shares reported at quarter-end
Q3 2013
Sold 38.0% of the position−950.00K shares · 1.55M shares remained
Filing context

Quarter-end price $92.15 · Estimated holding basis $80.40

Portfolio importance

How important was Thermo Fisher Scientific Inc in Third Point LLC’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.4%Q4 2025
Last reported rank#31of 44 reported positions
Peak portfolio weight4.8%Q2 2013
Best historical rank#4Q2 2013
At peak importanceQ2 2013
TMO
4.8%
Largest holding
35.4%
Cross-investor discovery

Who else owns Thermo Fisher Scientific Inc?

Also reported by 3 other tracked investors in their latest verified filings.

Stanley DruckenmillerDuquesne Family Office
TMO0.2% of reported portfolio
Joel GreenblattGotham Asset Management
TMO0.2% of reported portfolio
Ray DalioBridgewater Associates, LP
TMO0.0% of reported portfolio
Explore Thermo Fisher Scientific Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$609.822026-09-11

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Third Point LLC’s Form 13F disclosures, not Daniel Loeb’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.